primaryid$caseid$drug_seq$role_cod$drugname$prod_ai$val_vbm$route$dose_vbm$cum_dose_chr$cum_dose_unit$dechal$rechal$lot_num$exp_dt$nda_num$dose_amt$dose_unit$dose_form$dose_freq
100080748$10008074$1$PS$NPLATE$ROMIPLOSTIM$1$Subcutaneous$100 MUG, QWK$NA$$$$ 1052108$$125268$100$UG$POWDER FOR INJECTION$/wk
100114532$10011453$1$PS$KINERET$ANAKINRA$1$Transplacental$$NA$$D$D$$$NA$NA$$$
100153712$10015371$1$PS$XELJANZ$TOFACITINIB CITRATE$1$$UNK$NA$$$$$$203214$NA$$TABLET$
100157464$10015746$1$PS$MIRENA$LEVONORGESTREL$1$Intra-uterine$20 MCG/24HR, CONT$NA$$$$$$21225$20$UG$INTRAUTERINE DELIVERY SYSTEM$
100166832$10016683$1$PS$EFAVIRENZ$EFAVIRENZ$1$Oral$UNK$NA$$$$$$21360$NA$$FILM-COATED TABLET$
1000602218$10006022$1$PS$Trastuzumab Emtansine$ADO-TRASTUZUMAB EMTANSINE$1$Intravenous (not otherwise specified)$LAST DOSE PRIOR TO SAE: 12/FEB/2014$NA$$$$ 528272,1112506,11125806$$125427$190$MG$$Q3W
